Skip to main content

Table 1 Baseline characteristics and angiographic features according to smoking status

From: Impact of smoking on health-related quality of Life after percutaneous coronary intervention treated with drug-eluting stents: a longitudinal observational study

Characteristic

Persisitent smokers

(Nā€‰=ā€‰172)

Never smokers

(Nā€‰=ā€‰351)

Quitters

(Nā€‰=ā€‰126)

P Value

3 Groups

Persistent vs Never

Persistent vs Quitter

Never vs Quitter

Age (years)

60.27ā€‰Ā±ā€‰9.65

65.05ā€‰Ā±ā€‰9.32

60.21ā€‰Ā±ā€‰9.12

<0.001

<0.001

0.956

<0.001

Male n (%)

155 (90.1)

211 (60.1)

118 (93.7)

<0.001

<0.001

0.277

<0.001

Marital status n (%)

147 (85.5)

310 (88.3)

114 (90.5)

0.405

0.356

0.195

0.509

Body mass index (kg/m2)

25.79ā€‰Ā±ā€‰2.80

25.12ā€‰Ā±ā€‰2.91

25.91ā€‰Ā±ā€‰2.74

0.005

0.011

0.739

0.008

Risk Factors n (%)

ā€ƒDiabetes mellitus

33 (16.9)

89 (25.4)

19 (15.1)

0.015

0.029

0.679

0.021

ā€ƒHypertension

105 (61.0)

244 (69.5)

81 (64.3)

0.003

0.002

0.718

0.019

ā€ƒHypercholesterolemia

55 (32)

126 (35.9)

44 (34.9)

0.674

0.376

0.594

0.844

ā€ƒHeart failure

16 (9.3)

25 (7.12)

11 (8.73)

0.808

0.529

0.865

0.712

ā€ƒImpaired renal dysfunction

6 (3.5)

15 (4.3)

4 (3.2)

0.858

0.667

0.882

0.588

ā€ƒPrior AMI n (%)

30 (17.4)

36 (10.3)

23 (18.3)

0.021

0.020

0.856

0.019

ā€ƒUnstable angina

117 (68.0)

221 (63.0)

82 (65.1)

0.521

0.225

0.594

0.672

Left ventricular ejection fraction

65.52ā€‰Ā±ā€‰6.93

65.38ā€‰Ā±ā€‰8.84

66.28ā€‰Ā±ā€‰8.43

0.577

0.86

0.435

0.299

In-hospital laboratory test

ā€ƒFasting plasma glucose (mmol/L)

5.48ā€‰Ā±ā€‰1.55

5.77ā€‰Ā±ā€‰1.34

5.51ā€‰Ā±ā€‰1.26

0.170

0.125

0.477

0.229

ā€ƒTotal cholesterol (mmol/L)

4.07ā€‰Ā±ā€‰0.88

4.21ā€‰Ā±ā€‰1.35

4.16ā€‰Ā±ā€‰0.87

0.422

0.190

0.522

0.651

ā€ƒTriglycerides (mmol/L)

1.67ā€‰Ā±ā€‰0.93

1.58ā€‰Ā±ā€‰1.15

1.75ā€‰Ā±ā€‰1.13

0.308

0.393

0.532

0.141

ā€ƒHDL cholesterol (mmol/L)

0.96ā€‰Ā±ā€‰0.19

0.99ā€‰Ā±ā€‰0.20

0.98ā€‰Ā±ā€‰0.14

0.136

0.046

0.319

0.505

ā€ƒLDL cholesterol (mmol/L)

2.43ā€‰Ā±ā€‰0.77

2.31ā€‰Ā±ā€‰0.82

2.44ā€‰Ā±ā€‰0.78

0.122

0.085

0.974

0.114

In-hospital treatments n (%)

ā€ƒAntiplatalet

172 (100)

351 (100)

126 (100)

1.000

1.000

1.000

1.000

ā€ƒStatins

169 (98.3)

348 (99.1)

123 (97.6)

0.441

0.370

0.699

0.187

ā€ƒACEI/ARB

110 (64.0)

215 (61.3)

82 (65.1)

0.693

0.550

0.841

0.447

ā€ƒCCB

31 (18.0)

74 (21.1)

26 (20.6)

0.708

0.412

0.571

0.916

ā€ƒĪ²-blockers

87 (50.6)

190 (54.1)

66 (52.4)

0.742

0.445

0.759

0.735

No. of diseased vessels n (%)

Ā Ā Ā 

0.429

0.185

0.892

0.528

ā€ƒ1

85 (49.4)

158 (45.0)

61 (48.4)

Ā Ā Ā Ā 

ā€ƒ2

50 (29.1)

91 (25.9)

35 (27.8)

Ā Ā Ā Ā 

ā€ƒ3

37 (21.5)

102 (29.1)

30 (23.8)

Ā Ā Ā Ā 

Reference vessel diameter (mm)

2.95ā€‰Ā±ā€‰0.42

3.01ā€‰Ā±ā€‰0.40

2.96ā€‰Ā±ā€‰0.34

0.213

0.100

0.732

0.277

Percentage diameter stenosis (%)

85.82ā€‰Ā±ā€‰12.31

84.61ā€‰Ā±ā€‰11.22

86.86ā€‰Ā±ā€‰11.55

0.146

0.260

0.446

0.062

B2/C class lesion n, (%)

129 (75.0)

253 (72.1)

99 (78.6)

0.344

0.480

0.472

0.155

Predilation n,(%)

148 (86.0)

299 (85.2)

111 (88.1)

0.722

0.793

0.604

0.420

Stent diameter (mm)

3.02ā€‰Ā±ā€‰0.41

3.08ā€‰Ā±ā€‰0.39

3.02ā€‰Ā±ā€‰0.34

0.104

0.074

0.982

0.104

Total stent length (mm)

32.18ā€‰Ā±ā€‰6.53

32.36ā€‰Ā±ā€‰7.00

33.56ā€‰Ā±ā€‰6.57

0.431

0.196

0.439

0.775

Stent delivery pressure (atm)

14.50ā€‰Ā±ā€‰2.31

14.39ā€‰Ā±ā€‰2.26

14.68ā€‰Ā±ā€‰2.05

0.435

0.583

0.487

0.202

Postdilation n,(%)

57 (33.1)

106 (30.2)

45 (35.7)

0.491

0.495

0.644

0.254

  1. AMI acute myocardial infarction, HDL high density lipid, LDL Low density lipid, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, CCB calcium channel blockers